Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 9Breast Neoplasms 7Carcinoma, Non-Small-Cell Lung 6Pancreatic Neoplasms 4Neoplasms 4Nasopharyngeal Carcinoma 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Neoplasm Metastasis 2Meningioma 2Liver Neoplasms 2HER2-positive Breast Cancer 2Glioma 2Glioblastoma 2Chordoma 2Carcinoma, Hepatocellular 2Carcinoma, Adenoid Cystic 2Brain Neoplasms 2Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Small Cell Lung Carcinoma 1Sinonasal undifferentiated carcinoma 1Resectable Lung Non-Small Cell Carcinoma 1Radiation Injuries 1Pituitary Neoplasms 1Oligodendroglioma 1Neurilemmoma 1Nerve Sheath Neoplasms 1

Interventions

Gemcitabine 113Cisplatin 77Oxaliplatin 46pembrolizumab 35Fluorouracil 33Capecitabine 31durvalumab 27Leucovorin 27lenvatinib 26Magnetic Resonance Spectroscopy 15Irinotecan 14Drug Therapy 13Biopsy 13Nivolumab 12Albumin-Bound Paclitaxel 12tislelizumab 11Specimen Handling 11Radiofrequency Ablation 11130-nm albumin-bound paclitaxel 11pemigatinib 10apatinib 10Taxes 10Radiotherapy 10Floxuridine 10Folfox protocol 9Bevacizumab 9S 1 (combination) 8Platinum 8Photochemotherapy 8Liver Transplantation 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholangiocarcinoma × Protons × Clear all
NCT00426829 2012-08-01

Proton Therapy and Bevacizumab for Primary Liver Tumors

M.D. Anderson Cancer Center

Phase 1 Terminated
3 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡